Related Experiment Video
Updated: Feb 12, 2026
11:58
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
39.4K
Noradrenergic Modulation on Dopaminergic Neurons.
1Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA. zhum@etsu.edu.
Neurotoxicity Research
|March 25, 2018
Summary
The locus coeruleus-norepinephrine (LC-NE) system modulates dopamine transmission, and its dysfunction is linked to Parkinson's disease. Understanding this neuroprotective LC-NE modulation offers potential therapeutic strategies for Parkinson's disease.
Area of Science:
- Neuroscience
- Neurobiology
- Neurochemistry
Background:
- A well-established link exists between noradrenergic and dopaminergic neurons.
- The locus coeruleus-norepinephrine (LC-NE) system modulates dopamine transmission.
- Dysregulation of this modulation may contribute to neurodegeneration in Parkinson's disease.
Purpose of the Study:
- To review evidence on the noradrenergic modulation of dopaminergic neurons.
- To explore the neuroprotective effects of the LC-NE system on dopaminergic neurons.
- To elucidate the mechanisms underlying LC-NE modulation.
Main Methods:
- Review of existing literature on LC-NE system and dopaminergic pathways.
- Illustration of noradrenergic innervation and functional implications.
- Depiction of in vivo and in vitro neuroprotective effects of LC-NE.
Main Results:
- The LC-NE system exerts neuroprotective effects on dopaminergic neurons.
- Norepinephrine (NE) acts as a neurotrophic factor and stimulates other neurotrophic factors like BDNF.
- Potential mechanisms involve NE's intrinsic effects and its role in promoting neurotrophic factor expression.
Conclusions:
- Understanding noradrenergic modulation of dopaminergic neurons is crucial for Parkinson's disease research.
- This knowledge may lead to significant advances in the etiological study of Parkinson's disease.
- Further insights could pave the way for promising therapeutic interventions for Parkinson's disease.
Related Concept Videos
01:28Neuronal Communication
3.5K
Neurons, the fundamental units of the brain and nervous system, communicate through complex electrochemical signals that underpin all cognitive and bodily functions. This communication is primarily facilitated by a process involving the generation and propagation of an action potential along the axon of the neuron. When the internal electrical charge of a neuron surpasses a certain threshold, an action potential is triggered. This rapid change in voltage travels swiftly along the axon to the...
3.5K
01:21Neurons: The Axon
7.5K
Axons are long, cytoplasmic processes of nerve cells capable of propagating electrical impulses known as action potentials. The cytoplasm or axoplasm of an axon contains neurofibrils, neurotubules, small vesicles, lysosomes, mitochondria, and various enzymes, all encased within the axolemma, the plasma membrane of the axon.
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment....
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment....
7.5K
01:31Neuron Structure
232.1K
Overview
232.1K
01:30Neuron Structure
18.6K
Neurons are the main type of cell in the nervous system that generate and transmit electrochemical signals. They primarily communicate with each other using neurotransmitters at specific junctions called synapses. Neurons come in many shapes that often relate to their function, but most share three main structures: an axon and dendrites that extend out from a cell body.
Structure and Function of Neurons
The neuronal cell body—the soma— houses the nucleus and organelles vital to...
Structure and Function of Neurons
The neuronal cell body—the soma— houses the nucleus and organelles vital to...
18.6K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
926
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
926
01:27Adrenergic Neurons: Neurotransmission
5.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.4K